Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,041 | 201 | 99.0% |
| Education | $41.19 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $438.36 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $295.62 | 13 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $266.20 | 15 | $0 (2023) |
| Lilly USA, LLC | $251.20 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $249.34 | 13 | $0 (2024) |
| Gilead Sciences, Inc. | $243.22 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $212.19 | 12 | $0 (2024) |
| Eisai Inc. | $171.59 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $140.67 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $120.19 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,507 | 72 | Gilead Sciences, Inc. ($182.84) |
| 2023 | $2,134 | 105 | Merck Sharp & Dohme LLC ($278.42) |
| 2022 | $392.08 | 22 | Pharmacyclics LLC, an AbbVie Company ($136.19) |
| 2021 | $49.49 | 4 | Janssen Biotech, Inc. ($13.71) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.85 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | REBLOZYL (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Oncology | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Oncology | ||||||
| 06/05/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Oncology | ||||||
| 05/23/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Oncology | ||||||
| 05/22/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Oncology | ||||||
| 05/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.08 | General |
| 05/18/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Oncology | ||||||
| 05/17/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 05/13/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Oncology | ||||||
| 05/09/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.28 | General |
| Category: Hematology | ||||||
| 05/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 252 | 309 | $79,817 | $14,357 |
| 2022 | 2 | 45 | 104 | $26,584 | $4,990 |
| 2021 | 3 | 46 | 61 | $18,231 | $3,651 |
| 2020 | 2 | 84 | 117 | $28,325 | $6,971 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 130 | 167 | $34,431 | $6,583 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 84 | 104 | $32,919 | $6,151 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 27 | 27 | $10,015 | $1,399 | 14.0% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Facility | 2023 | 11 | 11 | $2,452 | $223.41 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 57 | $17,298 | $3,172 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 19 | 47 | $9,286 | $1,818 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 33 | $9,654 | $1,985 | 20.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $5,335 | $926.51 | 17.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 17 | $3,242 | $739.84 | 22.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 80 | $20,000 | $5,269 | 26.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 37 | $8,325 | $1,702 | 20.4% |
About John Powell, N.P
John Powell, N.P is a Family healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194725432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Powell, N.P has received a total of $4,083 in payments from pharmaceutical and medical device companies, with $1,507 received in 2024. These payments were reported across 203 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($4,041).
As a Medicare-enrolled provider, Powell has provided services to 427 Medicare beneficiaries, totaling 591 services with total Medicare billing of $29,970. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family, Family
- Location Memphis, TN
- Active Since 07/28/2005
- Last Updated 06/22/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1194725432
Products in Payments
- IMBRUVICA (Drug) $384.86
- KEYTRUDA (Biological) $344.06
- ENHERTU (Biological) $174.60
- Lenvima (Drug) $171.59
- DARZALEX (Biological) $163.55
- Trodelvy (Drug) $136.84
- CABOMETYX (Drug) $108.94
- REBLOZYL (Biological) $101.27
- LONSURF (Drug) $98.93
- VERZENIO (Drug) $92.75
- RETEVMO (Drug) $87.78
- PYRUKYND (Drug) $87.13
- INJECTAFER (Drug) $86.42
- KISQALI (Drug) $80.65
- Rezlidhia (Drug) $72.83
- JAYPIRCA (Drug) $70.67
- XTANDI (Drug) $68.23
- JEMPERLI (Biological) $65.54
- AYVAKIT (Drug) $65.39
- ZEJULA (Drug) $58.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Memphis
Mrs. Marye Bernard, Fnp, FNP
Family — Payments: $81,600
Artangela Henry, Dnp, Fnp-C, DNP, FNP-C
Family — Payments: $72,936
Brett Snodgrass, Fnpc, FNPC
Family — Payments: $35,324
John Scallions, Aprn, APRN
Family — Payments: $29,289
Ashley Mccurdy, Fnp, FNP
Family — Payments: $12,341
Dr. James Beasley, Dnp Ag-Acnp-Bc, Fnp-, DNP AG-ACNP-BC, FNP-
Family — Payments: $11,184